A study at MedUni Vienna's Department of Dermatology provides insights into the diversity of cancer-associated fibroblasts in ...
2hon MSN
Merck & Co. Inc.’s reported positive results Tuesday for a new, easier-to-administer formulation of its blockbuster cancer ...
If you break your leg, ‘I’m in pain, I need fixing’. I never actually felt ill. I never felt a lump, nothing. I was picked up ...
Cancer occurs when genetic changes disrupt normal cell functions. These genetic mutations can be inherited; they can happen spontaneously when cells make copies of themselves; or they can be caused by ...
If you break your leg, ‘I’m in pain, I need fixing’. I never actually felt ill. I never felt a lump, nothing. I was picked up ...
Analysts are split on whether the positive trial results will help Merck stem future Keytruda losses as the mega-blockbuster ...
Subcutaneous pembrolizumab matched IV Keytruda in key pharmacokinetic metrics in a Phase 3 NSCLC trial. Safety and efficacy ...
The mohs team at Chorley and Hospital. Lancashire Teaching Hospitals has launched a first-of-its-kind service in the region ...
Merck's new formulation could help secure a larger share of Keytruda's sales after the cancer drug's U.S. patent expires in ...
From making skin cancer detection easier to making drone delivery safer, these companies are showing that good things can ...
A BEAUTY guru has revealed the anti-ageing treatment that she swears by after working in the industry for 20 years. Georgia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback